WHO Expert Committee on drug dependence

World Health Organization - Technical Report Series

Volumn , Issue 915, 2003, Pages

  Bourin, M S ^a   Zhiji, Cai ^b   De Lima, L ^c   Elmi, A S ^d   Haghighi, S ^e   Ombaka, E M A ^f   Schuster, C R ^g   Suryawati, S ^h   Suzuki, T ⁱ   Wieniawski, W ^j  

^a UNIVERSITÉ DE NANTES   (France)

^b National Institute on Drug Dependence   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Rexdale Health Centre   (Canada)

^e PASTEUR INSTITUTE OF IRAN   (Iran)

^f Ecumenical Pharmaceutical Network   (Kenya)

^g WAYNE STATE UNIVERSITY   (United States)

^h GADJAH MADA UNIVERSITY   (Indonesia)

ⁱ HOSHI UNIVERSITY   (Japan)

^j Polish Pharmacopoeia Commission   (Poland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMFEPRAMONE; AMINEPTINE; BUPRENORPHINE; BUTORPHANOL; CATHA EDULIS EXTRACT; DRONABINOL; KETAMINE; NARCOTIC AGENT; ORIPAVINE; PSYCHOTROPIC AGENT; TRAMADOL; ZALEPLON; ZOPICLONE;

CENTRAL NERVOUS SYSTEM; CONTROL SYSTEM; DRUG ABUSE; DRUG CONTROL; DRUG DEPENDENCE; EXPERT SYSTEM; INTERNATIONAL COOPERATION; PRACTICE GUIDELINE; QUALITY CONTROL; RESPONSIBILITY; REVIEW; WORLD HEALTH ORGANIZATION;

EID: 0041519427     PISSN: 05123054     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (14)

1. Guidelines for the WHO review of dependence-producing psychoactive substances for international control (reprinted from document EB 105/2000/REC/1, Annex 9).
2. Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol amending the Single Convention on Narcotic Drugs, 1961. New York, United Nations, 1972.
3. Convention on Psychotropic Substances, 1971. New York, United Nations, 1977.
4. WHO Expert Committee on Drug Dependence. Thirty-second report. Geneva, World Health Organization, 2001 (WHO Technical Report Series, No. 903).
5. Review of psychoactive substances for international control, Geneva, 22-24 September 1980. Geneva, World Health Organization, 1980 (unpublished document WHO/MNH/80.28; available on request from Essential Drugs and Medicines Policy, World Health Organization, 1211 Geneva 27, Switzerland).
6. Seventh review of psychoactive substances for international control, Geneva, 7-11 March 1983. Geneva, World Health Organization, 1983 (unpublished document WHO/MNH/83.7; available on request from Essential Drugs and Medicines Policy, World Health Organization, 1211 Geneva 27, Switzerland).
7. WHO Expert Committee on Drug Dependence. Twenty-fifth report. Geneva, World Health Organization, 1989 (WHO Technical Report Series, No. 775).
8. WHO Expert Committee on Drug Dependence. Twenty-seventh report. Geneva, World Health Organization, 1991 (WHO Technical Report Series, No. 808).
9. WHO Expert Committee on Drug Dependence. Twenty-eighth report. Geneva, World Health Organization, 1993 (WHO Technical Report Series, No. 836).
10. WHO Expert Committee on Drug Dependence. Twenty-ninth report. Geneva, World Health Organization, 1995 (WHO Technical Report Series, No. 856).
11. Fourth review of psychoactive substances for international control, Geneva, 14-18 September 1981. Geneva, World Health Organization, 1981 (unpublished document WHO/MNH/83.7; available on request from Essential Drugs and Medicines Policy, World Health Organization, 1211 Geneva 27, Switzerland).
12. WHO Advisory Group. The dependence potential of thebaine. Report of a WHO Advisory Group. Bulletin on Narcotics, 1980, 32:45-54.
13. United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988. New York, United Nations, 1991.
14. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical descriptions and diagnostic guidelines. Geneva, World Health Organization, 1992.